Equities
  • Price (EUR)1.16
  • Today's Change-0.057 / -4.67%
  • Shares traded3.00k
  • 1 Year change-74.30%
  • Beta--
Data delayed at least 15 minutes, as of Nov 29 2022 08:36 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Clover Health Investments, Corp. is a physician enablement company. The Company is focused on seniors who have historically lacked access to affordable healthcare. It offers a software platform, Clover Assistant, which is designed to aggregate patient data from across the health ecosystem to support clinical decision-making and improve health outcomes. The Company operates under two segments: Insurance and Non-Insurance. Through its insurance line of business, it provides Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) plans to Medicare Advantage (MA) members in several states. The Company's non-insurance line of business focuses on reducing expenditures and enhancing the quality of care for patients enrolled in fee-for-service Medicare.

  • Revenue in USD (TTM)3.01bn
  • Net income in USD-442.00m
  • Incorporated2021
  • Employees680.00
  • Location
    Clover Health Investments Corp3401 Mallory Lane, Suite 210, Suite 320FRANKLIN 37067United StatesUSA
  • Phone+1 (201) 432-2133
  • Fax+1 (302) 655-5049
  • Websitehttps://www.cloverhealth.com/
More ▼
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.